You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information. Switch to the US site. 

This website uses cookies

By continuing to use this website you consent to using cookies. For more information about cookies and how we use them, please see our Privacy Policy.

Clinical and Economical Evidence

Intermittent Pneumatic Compression (IPC) has proved to be a very safe and effective method for promoting patient wellness, by reducing the immediate and long-term costs associated with Deep Vein Thrombosis (DVT).

More about VTE Prevention

The Arjo Clinical Evidence Document presents a comprehensive summary of the key clinical and economic evidence.

Topics covered include:

  • The global impact of Venous Thromboembolism (VTE).
  • The pathophysiology of VTE.
  • The risks, according to each clinical speciality.
  • Intermittent Pneumatic Compression (IPC) – mode of action.
  • Summary of consensus guidelines.
  • A comprehensive listing of key laboratory, clinical and safety studies related to Flowtron™ IPC devices.
  • Full reference listing.


Please click here to download Arjo Clinical Evidence Brochure.

Clinical Evidence Brochure